CAAP Company: Swift Medical Closes Over Subscribed Funding Round

OBIO CAAP 2016 company, Swift Medical, a market leader in machine vision and machine learning platforms for mobile health and data analytics, today announced completing a rounds of funding led by Montreal's Real Ventures with participation from Relay Ventures, Lumira Capital, MaRS IAF and a strategic partner. This round of funding will allow Swift to continue fueling its growth and expand into new markets.

Click HERE to read the full press release

Previous
Previous

OBIO Member: Focal Healthcare Inc Receives Health Canada Approval

Next
Next

OBIO + JLABS Team Up for You